Trending Now
ADMA Biologics Inc (NASDAQ:ADMA) Starts Collecting Plasma From Patients That Recovered...
Biopharmaceutical company ADMA Biologics Inc (NASDAQ:ADMA) has started collecting convalescent plasma from patients who have recovered after contracting the coronavirus.
The company revealed that it...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Wall Street Reporter Publishes Comments From Pharmadrug Inc (OTCMKTS: LMLLF), Biodesix...
Wall Street recently published comments from the company CEOs of Pharmadrug Inc (OTCMKTS: LMLLF), Biodesix Inc (NASDAQ: BDSX), Nova Mentis Life Sciences (OTCMKTS: NMLSF),...
MAKE IT MODERN
LATEST REVIEWS
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Posts Revenues Of $62.4 Million In Q2...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) reported a growth of 41% YoY to $62.4 million in Q2 2020. It is on the backdrop of strong patient...
MAKE IT MODERN
PERFORMANCE TRAINING
Aimmune Therapeutics Inc (NASDAQ:AIMT) Announces the Findings from APPEAL-2 Evaluating Impact of Peanut Allergy...
We all know what it means to live with the threats of an allergy. There are hundreds of thousands of people living with life-threatening...
Qualigen Therapeutics Inc. ((NASDAQ: QLGN) Announce Global In-License for QN-302 For Treatment of Pancreatic...
Qualigen Therapeutics Inc. (NASDAQ: QLGN) has announced an exclusive global in-license of genomic quadruplex (G4) selective transcription inhibitor development program that includes preclinical data,...
Transocean LTD (NYSE: RIG) Reports a Net Loss Attributable to Controlling Interest of $103...
Transocean LTD (NYSE: RIG) recently announced its financial results for the second quarter of 2021. In the report, the company announced a net loss...
ZyVersa Therapeutics, Inc. (ZVSA): A 38.8% Stock Surge Highlights Innovative Approach to Inflammatory Disease...
ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA), a clinical-stage specialty biopharmaceutical company based in Weston, Florida, saw a significant stock boost of 38.8%, closing...
ABVC BioPharma Inc. (NASDAQ: ABVC) Announces Q3 2021 Net loss of $1.9M and Nasdaq...
ABVC BioPharma Inc. (NASDAQ: ABVC) has announced its operating and financial Q3 2021, ending September 30, 2021.
Q3 revenue of $98,999
Revenue in Q3 2021 was...
MAKE IT MODERN
